Erythromycin

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 07.11.2023

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Mixture of substances consisting of structurally very similar compounds formed by the bacterium Saccharopolyspora erythraea and used as a drug due to its antibiotic effect.

The main component of the substance mixture is erythromycin A. Other ingredients are erythromycin B (5%) and, to a much lesser extent, erythromycin C. Chemically, erythromycin can be described as a glycoside; pharmacologically, erythromycin is a macrolide antibiotic.

Half-lifeThis section has been translated automatically.

1,6 h

Spectrum of actionThis section has been translated automatically.

Bacillus anthracis, Bacterioides ureolyticus, Bordetella, Borrelia, Campylobacter, Chlamydia, Clostridium spp. difficile), Corynebacterium diphtheriae, Entamoeba histolytica, Eikenella corrodens, Erysipelothrix rusiopathiae, Gardnerella vaginalis, Haemophilus ducreyi, Helicobacter pylori, Legionella pneumophilia, Listeria monocytogenes, Mobiluncus spp, Moraxella catarrhalis, Mycoplasma pneumoniae, Neisseria, Peptostreptococcus spp., Prevotella spp., Propionibacterium acnes, Rochalimaea spp., Staphylococcus spp., Streptococcus spp., Treponema pallidum.

Notice!

Cross-resistance to other macrolide antibiotics, including clindamycin!

IndicationThis section has been translated automatically.

Tonsillitis, pharyngitis, otitis media, whooping cough, pneumonia, skin infections, syphilis, gonorrhea, ulcus molle, diphtheria. Substitute preparation for penicillin allergy; topically for the treatment of acne papulopustulosa and for Crédé's prophylaxis.

Limited indicationThis section has been translated automatically.

In case of systemic application: liver dysfunction, pregnancy, lactation, myasthenia gravis.

Pregnancy/nursing periodThis section has been translated automatically.

Erythromycin orally justified only during pregnancy. Careful benefit-risk assessment. Substance passes into breast milk.

Dosage and method of useThis section has been translated automatically.

  • Systemic:
    • Pat. > 14 yrs.: 1.5-2 g/day p.o. or i.v.
    • Children/adolescents 8-14 yrs: 30 mg/kg bw/day p.o. in 4 ED or 20-30 mg/kg bw i.v.
  • Topical:
    • Eye ointment: Apply 0.5 cm ointment into the conjunctival sac every 2 hours.
    • Solution/gel/ointment/cream: After thorough skin cleansing, apply a thin layer twice a day to the affected skin areas.

Note! Do not use for more than 10-12 weeks due to the development of resistance. Do not use together with alcoholic benzoyl peroxide solutions.

Standard concentrationThis section has been translated automatically.

  • 1% as eye ointment.
  • 0.5-, 1-, 2- or 4% in solutions, gels, ointments and creams.

Undesirable effectsThis section has been translated automatically.

  • The most common adverse events in systemic erythromycin application are gastrointestinal side effects such as gastrointestinal cramps, nausea, vomiting, diarrhea. Furthermore: allergic reactions, reversible intrahepatic cholestasis.
  • With top. Appl. Erythema, peeling, burning, scaling, contact dermatitis, pruritus.

Notice. In case of persistent diarrhea and colics think of pseudomembranous colitis!

InteractionsThis section has been translated automatically.

s. Table 1.

ContraindicationThis section has been translated automatically.

Hypersensitivity.

Recipe(s)This section has been translated automatically.

In magistral prescriptions, standardized formulations such as those found in the NRF as"Hydrophilic Erythromycin Cream" (NRF11.77) are recommended.

Further erythromycin-containing formulations are:

PreparationsThis section has been translated automatically.

Aknemycin (as ointment or solution); Erythrocin i.v.; Erythrocin Neo; Paediathrocin; Aknemycin; Ecolicin eye ointment; Ecolicin eye drops; Sanasepton gel 2%/-4%; Inderm gel 2%/-4%.

Erythromycin 500 Ratiopharm®

Note(s)This section has been translated automatically.

Erythromycin has an extremely stable behavior in the alkaline range. The optimum stability should always be artificially adjusted to a pH between 8.0-8.5. In acidic conditions it is hydrolytically inactivated within 1-3 hours! Combination with the acid-labile clotrimazole is possible. In contrast, the combination of erythromycin with various glucocorticoids (stability optima are often in the acidic range) is not very useful, as instabilities often occur due to different pH values (e.g. with a prednicarbate/erythromycin mixture). An exception is triamcinolone acetonide, which has its optimum pH at pH 7. At pH 7, 4 times the amount of erythromycin is required in a formulation for the same efficacy.

LiteratureThis section has been translated automatically.

  1. Garcia-Lechuz JM et al (2007) Spanish Pneumococcal Study Network. Streptococcus pneumoniae skin and soft tissue infections: characterization of causative strains and clinical illness. Eur J Clin Microbiol Infect Dis 26: 247-253
  2. Wolff G (2009) Formulation tip: Many active ingredients - higher compatibility risk. Dermatologist 60: 534-535
  3. Wolff G (2013) Formulation tip: Individual formulations with ready-to-use dermatics. Dermatologist 64: 882-883

TablesThis section has been translated automatically.

Significant interactions of erythromycin

Anticoagulants, oral

Bleeding tendency ↑

Carbamazepine

Carbamazepine levels ↑

Ciclosporin

Ciclosporin levels ↑

Digoxin

Digoxin level ↑

Dihydroergotamine

Vasoconstriction ↑

Lincomycine

mutual effect ↓

Theophylline

Theophylline levels ↑

Authors

Last updated on: 07.11.2023